DOCSLIB.ORG

Prenatal Diagnosis by FISH of a 22Ql 1 Deletion in Two Families J Med Genet: First Published As 10.1136/Jmg.35.2.165 on 1 February 1998

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Prenatal Diagnosis by FISH of a 22Ql 1 Deletion in Two Families J Med Genet: First Published As 10.1136/Jmg.35.2.165 on 1 February 1998 I Med Genet 1998;35:165-168 165 Prenatal diagnosis by FISH of a 22ql 1 deletion in two families J Med Genet: first published as 10.1136/jmg.35.2.165 on 1 February 1998. Downloaded from Marie-France Portnoi, Nicole Joye, Marie Gonzales, Suzanne Demczuk, Laurent Fermont, Gilles Gaillard, Guy Bercau, Genevieve Morlier, Jean-Louis Taillemite Abstract balanced translocation t(I 1;22)(q23;ql 1) was We report on prenatal diagnosis by FISH shown in the father's karyotype; in the second of a sporadic 22qll deletion associated case trisomy X was associated with a 22ql 1 with DiGeorge syndrome (DGS) in two deletion in the fetus. fetuses after an obstetric ultrasonographic examination detected cardiac anomalies, Materials and methods an interrupted aortic arch in case 1 and KARYOTYPING AND FISH tetralogy of Fallot in case 2. The parents Fetal blood samples were obtained for karyo- decided to terminate the pregnancies. At type analysis and FISH. Cells were harvested necropsy, fetal examination showed char- from cultures of phytohaemagglutinin stimu- acteristic facial dysmorphism associated lated lymphocytes and spread onto slides for with congenital malformations, confirm- the production of G banded or R banded chro- ing full DGS in both fetuses. In addition to mosomes. the 22ql 1 deletion, trisomy X was found in FISH of metaphase chromosomes using dig- the second fetus and a reciprocal balanced oxigenin labelled cosmid probes D22S75 translocation t(l 1 ;22) (q23;ql 1) was found (N25, ONCOR) from the DGS chromosome in the clinically normal father of case 1. region was carried out basically according to These findings highlight the importance Pinkel et al.' This probe was premixed with a of performing traditional cytogenetic control cosmid (D22S39) in 22q13.3 facilitat- analysis and FISH in pregnancies with a ing chromosome identification. high risk of a deletion. Service d'Embryologie having Pathologique et de (7Med Genet 1998;35:165-168) Case reports Cytogenetique, Hopital CASE 1 Saint-Antoine, 75012 Keywords: DiGeorge syndrome; chromosome 22ql1; FISH; microdeletion A 31 year old, nulliparous woman, who had Paris, France had a previous miscarriage at 8 weeks of gesta- M-F PortnoY N Joye tion, was seen for fetal echocardiography at 23 M Gonzales DiGeorge syndrome (DGS), an aetiologically weeks of gestation after an obstetric ultrasono- http://jmg.bmj.com/ G Morlier heterogeneous developmental field defect of graphic examination detected cardiac anoma- J-L Taillemite the third and fourth pharyngeal pouches, is lies and absence of the thymic shadow. Fetal characterised by hypoplasia or aplasia of the echocardiography showed an interrupted aor- Cytogenetics, Prenatal tic arch (IAA) associated with a membranous Diagnosis, Montreal thymus and parathyroid glands, a conotruncal Children's Hospital, heart defect, and varying craniofacial ventricular septal defect. The possibility of Montreal, Quebec, dysmorphism.' DGS is frequently associated DGS was discussed because of its strong Canada with a chromosome 22 abnormality. Unbal- association with IAA and absence of the on September 26, 2021 by guest. Protected copyright. S Demczuk anced translocations which result in mono- thymus. A fetal blood sample was obtained for somy of 22pter-22ql 1 and interstitial deletions karyotype determination. A 46,XX karyotype Unite d'Explorations with a 22ql 1 deletion detected by FISH was Cardiologiques, have mapped the DGS region to 22ql 1.2.2 3 Institut de Molecular studies using probes for various found, consistent with the DG phenotype and Puericulture de Paris, loci in the 22ql 1 region have detected sub- provided a prenatal diagnosis of DGS (fig 1). 75014 Paris, France microscopic deletions in more than 90% The serum calcium level was determined and L Fermont of DGS cases without visible cytogenetic showed hypocalcaemia (66 mg/l, normal fetal Service de Gynecologie abnormalities.4 6 et Obstetrique, H6pital Deletions within 22q1 1 are associated with a Saint-Antoine, 75012 wide variety of birth defects embraced by the Paris, France acronym CATCH 22,7 including Sprintzen G Gaillard syndrome (velocardiofacial syndrome), Service de Gynecologie conotruncal congenital heart disease, and DGS et Obstetrique, H6pital at the more severe end ofthe clinical spectrum. Notre-Dame de This haploinsufficiency of 22ql 1 is a relatively Bon-Secours, 75014 frequent cause of birth defect (1/5000 live Paris, France births).8 Fluorescence in situ hybridisation G Bercau (FISH) using unique sequence DNA probes is Correspondence to: an efficient, quick, and direct method for Dr Portnoi. detection of 22q 1 microdeletions. We report on prenatal diagnosis by FISH of Received 8 April 1997 a 22ql 1 deletion associated with DGS in two Figure 1 Partial metaphase spread showing lack ofsignal Revised version accepted for on one ofthe chromosomes 22. The deleted chromosome 22 publication 30 September families. Both of these cases are sporadic. with distal q arm marker present, but without DiGeorge 1997 Moreover, in the first case, a reciprocal probe signal is indicated by an arrowhead. 166 Portnoi, j7oyi, Gonzales, et al J Med Genet: first published as 10.1136/jmg.35.2.165 on 1 February 1998. Downloaded from Figure 4 Partial metaphase spread of thefather of case 1 after FISH showing a fluorescent signal on both chromosome 22 homologues at 22q11.2 with probe D22S75 (ONCOR) and at 11q23 on der(l 1) and on normal chromosome 22 with probe D22S39. levels 90.2 + 8 mg/i). T cell subpopulation .... studies were not performed. The parents were informed about the risks and decided to termi- nate the pregnancy. At necropsy, fetal examination showed facial dysmorphism with hypertelorism, a square nasal tip, a small, recessed chin, and a small hypoplastic thymus (fig 2). Cardiac examin- Figure 2 Fetus 1. ation confirmed the ultrasonographic findings. The aortic arch ended after the left common carotid artery, consistent with type B interrup- tion, and was associated with a ventricular sep- A tal defect. Neither parent had any evidence of a 22ql 1 deletion by FISH. The mother had normal chromosomes and the father was found to have a balanced reciprocal translocation involving chromosome 22, t(l 1;22)(q23;ql 1). CASE 2 http://jmg.bmj.com/ Fetal blood was obtained for karyotype analysis from a fetus whose mother and father were 27 and 40 years of age, respectively. Prenatal ultrasound examination at 23 weeks showed tetralogy of Fallot (TF). The fetus was found to have a 47,XXX karyotype and a 22qll deletion detected by FISH. Neither the serum calcium level nor the on September 26, 2021 by guest. Protected copyright. lymphocyte population was evaluated in this case. The TF associated with a 47,XXX karyo- type and a 22ql 1 deletion had obvious implications for genetic counselling and risk assessment. Following counselling the preg- nancy was terminated. At necropsy, the fetus had facial dysmorphic features including a broad nose, downward slanting palpebral fissures with hypertelorism, a small mouth, microstomia, micrognathia, rounded, posteriorly rotated ears with absent ear lobes, and facial hypertrichosis (fig 3). TF was associated with a complete absence of the thymus, vertebral anomalies, and a left talipes equinovarus deformity. The parental karyotypes were both normal. Deletion 22q1 1 was excluded by FISH. Discussion Very few data are available concerning the prognosis for fetuses diagnosed prenatally as Fr having a 22ql 1 deletion. To the best of our Figure 3 Fetus 2. knowledge only three cases of prenatally Prenatal diagnosis by FISH of a 22ql1 deletion 167 diagnosed DGS with a 22ql 1 deletion have patients with DGS who have survived infancy been published. have been mildly to moderately retarded.' Van Hemel et al' described a familial case The presence of a deletion associated with J Med Genet: first published as 10.1136/jmg.35.2.165 on 1 February 1998. Downloaded from illustrating the variable clinical expression of conotruncal heart disease is an important point the chromosome 22ql 1 deletion. A 22ql 1 which has obvious implications for genetic deletion was found in a child who died two counselling. In both of our cases, necropsy weeks after birth with symptoms of full DGS confirmed that the fetuses were severely and truncus arteriosus. This deletion was affected and had multiple congenital anoma- detected in the physically normal father who lies. This study, the first to our knowledge that had mild learning disabilities and a tendency to describes fetal examination of DGS with a depression, as well as in a subsequent preg- 22ql 1 deletion, has shown that facial dysmor- nancy. Ultrasound studies did not show cardiac phism is present and recognisable in the fetus or other anomalies in the latter fetus. At birth and is very similar to that of the newborn. the boy developed hypocalcaemia and had a Furthermore, in our report, karyotype moderate T cell deficit. Echocardiography analysis showed a second chromosomal showed a right sided aortic arch without abnormality. In the first case, the father was intracardiac anomalies. found to have a balanced translocation Puder et al" reported a case of prenatally t(1 1;22)(q23;ql 1). FISH analysis showed diagnosed IAA, which led to the detection of D22S75 to be present on the derivative 22 segmental monosomy of chromosome 22qll translocation chromosome and to be located by FISH in the fetus and in his mother, who centromeric to the translocation breakpoint in had a small ventricular septal defect. 22ql1 (fig 4). The presence of a 22ql 1 The first case of prenatal detection of a fetus deletion in the offspring oft(l 1;22) carriers has with an interrupted aortic arch and a 22qll not been reported previously. An attractive deletion, in the absence of a family history, was hypothesis is that this recurrent translocation reported by Davidson et al. 12 The mother was in the father may have played a role in the also found to carry the deletion; she had no existence ofthe deletion in the fetus.
Load more

Recommended publications
  • Sema4 Noninvasive Prenatal Select
    Sema4 Noninvasive Prenatal Select Noninvasive prenatal testing with targeted genome counting 2 Autosomal trisomies 5 Trisomy 21 (Down syndrome) 6 Trisomy 18 (Edwards syndrome) 7 Trisomy 13 (Patau syndrome) 8 Trisomy 16 9 Trisomy 22 9 Trisomy 15 10 Sex chromosome aneuploidies 12 Monosomy X (Turner syndrome) 13 XXX (Trisomy X) 14 XXY (Klinefelter syndrome) 14 XYY 15 Microdeletions 17 22q11.2 deletion 18 1p36 deletion 20 4p16 deletion (Wolf-Hirschhorn syndrome) 20 5p15 deletion (Cri-du-chat syndrome) 22 15q11.2-q13 deletion (Angelman syndrome) 22 15q11.2-q13 deletion (Prader-Willi syndrome) 24 11q23 deletion (Jacobsen Syndrome) 25 8q24 deletion (Langer-Giedion syndrome) 26 Turnaround time 27 Specimen and shipping requirements 27 2 Noninvasive prenatal testing with targeted genome counting Sema4’s Noninvasive Prenatal Testing (NIPT)- Targeted Genome Counting analyzes genetic information of cell-free DNA (cfDNA) through a simple maternal blood draw to determine the risk for common aneuploidies, sex chromosomal abnormalities, and microdeletions, in addition to fetal gender, as early as nine weeks gestation. The test uses paired-end next-generation sequencing technology to provide higher depth across targeted regions. It also uses a laboratory-specific statistical model to help reduce false positive and false negative rates. The test can be offered to all women with singleton, twins and triplet pregnancies, including egg donor. The conditions offered are shown in below tables. For multiple gestation pregnancies, screening of three conditions
    [Show full text]
  • REVIEW ARTICLE Genetic Factors in Congenital Diaphragmatic Hernia
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector REVIEW ARTICLE Genetic Factors in Congenital Diaphragmatic Hernia A. M. Holder,* M. Klaassens,* D. Tibboel, A. de Klein, B. Lee, and D. A. Scott Congenital diaphragmatic hernia (CDH) is a relatively common birth defect associated with high mortality and morbidity. Although the exact etiology of most cases of CDH remains unknown, there is a growing body of evidence that genetic factors play an important role in the development of CDH. In this review, we examine key findings that are likely to form the basis for future research in this field. Specific topics include a short overview of normal and abnormal diaphragm development, a discussion of syndromic forms of CDH, a detailed review of chromosomal regions recurrently altered in CDH, a description of the retinoid hypothesis of CDH, and evidence of the roles of specific genes in the development of CDH. Congenital diaphragmatic hernia (CDH [MIM 142340, Overview of Normal and Abnormal Diaphragm 222400, 610187, and 306950]) is defined as a protrusion Development of abdominal viscera into the thorax through an abnormal opening or defect that is present at birth. In some cases, this protrusion is covered by a membranous sac. In con- The development of the human diaphragm occurs be- trast, diaphragmatic eventrations are extreme elevations, tween the 4th and 12th wk of gestation. Traditional views rather than protrusions, of part of the diaphragm that is of diaphragm development suggest that the diaphragm 9 often atrophic and abnormally thin. CDH is a relatively arises from four different structures.
    [Show full text]
  • Structural and Numerical Changes of Chromosome X in Patients with Esophageal Atresia
    European Journal of Human Genetics (2014) 22, 1077–1084 & 2014 Macmillan Publishers Limited All rights reserved 1018-4813/14 www.nature.com/ejhg ARTICLE Structural and numerical changes of chromosome X in patients with esophageal atresia Erwin Brosens*,1,2,5, Elisabeth M de Jong1,2,5, Tahsin Stefan Barakat3, Bert H Eussen1, Barbara D’haene4, Elfride De Baere4, Hannah Verdin4, Pino J Poddighe1, Robert-Jan Galjaard1, Joost Gribnau3, Alice S Brooks1, Dick Tibboel2 and Annelies de Klein1 Esophageal atresia with or without tracheoesophageal fistula (EA/TEF) is a relatively common birth defect often associated with additional congenital anomalies such as vertebral, anal, cardiovascular, renal and limb defects, the so-called VACTERL association. Yet, little is known about the causal genetic factors. Rare case reports of gastrointestinal anomalies in children with triple X syndrome prompted us to survey the incidence of structural and numerical changes of chromosome X in patients with EA/TEF. All available (n ¼ 269) karyotypes of our large (321) EA/TEF patient cohort were evaluated for X-chromosome anomalies. If sufficient DNA material was available, we determined genome-wide copy number profiles with SNP array and identified subtelomeric aberrations on the difficult to profile PAR1 region using telomere-multiplex ligation-dependent probe amplification. In addition, we investigated X-chromosome inactivation (XCI) patterns and mode of inheritance of detected aberrations in selected patients. Three EA/TEF patients had an additional maternally inherited X chromosome. These three female patients had normal random XCI patterns. Two male EA/TEF patients had small inherited duplications of the XY-linked SHOX (Short stature HOmeoboX-containing) locus.
    [Show full text]
  • 95 Birth Defects Exec Summ
    Executive Summary In 1995, 865 cases of birth defects were detected among live born infants and fetuses of 20 or more weeks gestation delivered to mothers residing in Texas Public Health Regions 6 and 11 (Houston/Galveston region and Lower Rio Grande Valley). In this first full year of the Registry, surveillance was limited to approximately 23 major categories of birth defects, comprising 30 to 40 percent of all known structural malformations. Down syndrome, oral clefts, and spina bifida were the most common birth defects, although some major structural malformations were not yet monitored in 1995. Age Patterns: Both trisomy 21 (Down syndrome) and trisomy 18 (Edwards syndrome) demonstrated an age-specific rate pattern that was J-shaped, with the highest birth prevalence (“rates”) observed among mothers 35 years of age and older. Gastroschisis, a malformation of the abdominal wall, exhibited highest rates among the youngest mothers and decreased with each older age group. Racial/Ethnic Patterns: Anencephaly and spina bifida were lowest among African Americans; however, rates were similar in whites and Hispanics. Among the heart defects, relatively high rates of tetralogy of Fallot were observed among African Americans, although they exhibited relatively low rates of hypoplastic left heart. Cleft palate alone was more likely to occur among whites and Hispanics. Rates of trisomy 18 (Edwards syndrome) were highest among African Americans and whites. Gender Patterns: With regard to sex, higher rates were documented among females for anencephaly, and to a lesser extent, spina bifida. Females experienced two-fold higher rates of trisomy 18 (Edwards syndrome). Males had higher rates of cleft lip with or without cleft palate.
    [Show full text]
  • Genetic Testing Options
    GENETIC TESTING OPTIONS Most babies are born free of birth defects. Of those who are affected, the more common types are Trisomy defects, such as Down syndrome, and Open Neural Tube defects such as Spina Bifida. Testing is optional. Some people want genetic testing done as early as possible, to reassure them that their baby is normal, or to provide a diagnosis early enough in the pregnancy so that all options remain open. Others, who would not change their pregnancy plans in the event of a birth defect, seek to know whether the baby is normal or affected, and if there is a birth defect, to use the remainder of the pregnancy to educate themselves and prepare for a family member with special needs. It is also helpful for your doctor to be prepared for all eventualities. Still others prefer not to undergo any genetic testing. Our goal is to educate you about the options so that you can make a fully informed decision, as well as to support your decision. SCREENING TESTS A screening test is NOT the same as a diagnostic test. The screening process is basically a customized statistical risk assessment, to determine your personal risk. A positive screening test is NOT a diagnosis of a birth defect. It provides information that guides decisions about diagnostic testing. First Look Test (typically scheduled between 12wks-13wks 3days) The First Look Test is offered at Emerson Hospital MFM by Brigham & Women’s perinatologists and at Brigham & Women’s Hospital. It is a non-invasive test that assesses whether you are at increased risk of having a baby with Down syndrome or Trisomy 18.
    [Show full text]
  • Example Document Medical Genetics Center
    รายงานผลการตรวจววเคราะหย เลขทธรออางอนง : 00000 ศผนยยพวนธธศาสตรยการแพทยย 6/6 หมนม 6 ถนนสสขาภนบาล 5 ซอย 32 แขวงออเงนน เขตสายไหม กรสงเทพมหานคร 10220 Accreditation No.4148/57 โทรศกพทย/โทรสาร 086-8861203, 02-7920726 e-mail : [email protected] www.genetics.co.th ชชชอ น.ส............................. HN. ............. โรงพยาบาล .................................... ววนททชเกกบตววอยยาง 19 พฤศจนกายน 2558 12:55 แพทยยผผผสวชงตรวจ นพ.................................... ววนททชรวบตววอยยาง 20 พฤศจนกายน 2558 12:43 ววธทการตรวจ G-banding ชนวดตววอยยาง นนนาครรนา ขผอบยงชทชในการตรวจ Elderly Pregnancy หนยวยสยงตรวจ ไมมมธ Center document Genetics ผลการตรวจExample: 47,XXX คคาอธวบาย : ตรวจพบโครโมโซม 47 โครโมโซม,เปปนเพศหญนง,พบโครโมโซม X เกนนมา 1 โครโมโซม เขอาไดอกกบ Triple X Syndrome Medical หมายเหตธ: Band level 450 band ขผอจคากวดในการทดสอบ: ไมมสามารถตรวจสอบความผนดปกตนขนาดเลลกชนนด submicroscopic rearrangement หรรอ low-level mosaicism ไดอ ผผผรวบรองผล ( .................................. ) ววนททชออกรายงาน : ....................................... นพ.วทรยธทธ ประพวนธยพจนย,พบ.,วว.กธมารเวชศาสตรย American Board of Medical Genetics (Clinical Cytogenetics) Medical Genetics Center : Fo-QP-19/01 : 16-03-2015 : 02 เรียน อ.นพ...................................... ที่นับถือ ตามที่ผลตรวจโครโมโซมจากน ้าคร่้าของ นส........................ (HN .............., Lab no. ..............) พบ โครโมโซม X เกินมา 1 โครโมโซมนั น ความผิดปกติดังกล่าว เข้าได้กับกลุ่มอาการ trisomy X หรือ triple X syndrome ซึ่งเป็นความผิดปกติของโครโมโซมเพศที่พบได้บ่อยในทารกเพศหญิง โดยความผิดปกติของ โครโมโซมแบบนี
    [Show full text]
  • Inside This Issue
    Winter 2014 No. 77 Inside this issue Group News | Fundraising | Members’ Letters | One Family Living with Two Different Chromosome Disorders | Bristol Conference 2014 | Unique Leaflets | Christmas Card Order Form Sophie, Unique’s Chair of Trustees Dear Members, In the past month a few things have reminded me of why it is so important to make connections through Unique but also to draw support from other parents around us. I’ve just returned from Unique’s most recent family conference in Bristol where 150 of us parents and carers had a lovely time in workshops, meals and activities, chatting and watching our children milling around together like one big family since – although we had never met before – we have shared so many experiences in common. However in contrast I have also just met a new mum who has just moved to my area from far away with two toddlers, one with a rare joys of the internet, it is becoming easier to meet others with similar, chromosome disorder, who is starting from scratch with no even very rare, chromosome disorders around the world and to find professional, medical or social support. She reminds me of how yourself talking to them in the middle of the night about some lonely I felt when Max was newly diagnosed, when I knew no one interesting things our children share in common (obsession with with a disabled child let alone anyone with a rare chromosome catalogues, anyone?) And of course we also have an enormous disorder. Elsewhere our latest Unique Facebook group, Unique amount in common with so many parents of children with other Russia, is also just starting up – so far it includes just a small special needs or disabilities around us in our own communities who number of members sharing very different experiences to mine here will often be walking the same path as us.
    [Show full text]
  • Profile of Disorders of Sexual Differentiation in the Northeast
    The Egyptian Journal of Medical Human Genetics (2012) 13, 197–205 Ain Shams University The Egyptian Journal of Medical Human Genetics www.ejmhg.eg.net www.sciencedirect.com ORIGINAL ARTICLE Profile of disorders of sexual differentiation in the Northeast region of Cairo, Egypt Rabah M. Shawky a,*, Sahar M. Nour El-Din b a Pediatrics Department, Ain-Shams University, Egypt b Medical Genetics Center, Ain-Shams University, Egypt Received 26 September 2011; accepted 19 January 2012 Available online 27 April 2012 KEYWORDS Abstract This retrospective study has been conducted to determine the frequency, types, clinical Sex differentiation; presentation and associated genomic errors in patients with sex differentiation errors and their Intersex; relatives. The present study comprised of 908 index patients with sex differentiation errors who were Ambiguous genitalia; registered at the Medical Genetics Center (ASUMGC), Ain Shams University. Out of 28,736 Gonads; patients attending the center and 660,280 patients attending the Pediatrics clinic during the interval Genital surgery of 1966–2009. Our results showed that, the frequency among all patients attending the Pediatrics Hospital was 0.14%. Disorders of sex chromosome (Klinefelter syndrome and Turner syndrome) were the commonest, followed by mullerian dysgenesis. The commonest age of presentation was adolescence (>15–18 years) (36.56%), followed by patients aged 18 years or more (24.88%). In our study, 32.26% presented with primary female infertility, 27.86% adolescent girls presented with primary amenorrhea, 16.29% presented with male infertility, 10.35% presented with ambiguous gen- italia at birth or soon afterward, 6.60% were females who presented with delayed 2ry sexual charac- ters and short stature, 3.96% of our cases were boys who presented with microtestes and delayed 2ry sexual development and 2.75% presented with hirsutism.
    [Show full text]
  • Double Aneuploidy in Down Syndrome
    Chapter 6 Double Aneuploidy in Down Syndrome Fatma Soylemez Additional information is available at the end of the chapter http://dx.doi.org/10.5772/60438 Abstract Aneuploidy is the second most important category of chromosome mutations relat‐ ing to abnormal chromosome number. It generally arises by nondisjunction at ei‐ ther the first or second meiotic division. However, the existence of two chromosomal abnormalities involving both autosomal and sex chromosomes in the same individual is relatively a rare phenomenon. The underlying mechanism in‐ volved in the formation of double aneuploidy is not well understood. Parental ori‐ gin is studied only in a small number of cases and both nondisjunctions occurring in a single parent is an extremely rare event. This chapter reviews the characteristics of double aneuploidies in Down syndrome have been discussed in the light of the published reports. Keywords: Double aneuploidy, Down Syndrome, Klinefelter Syndrome, Chromo‐ some abnormalities 1. Introduction With the discovery in 1956 that the correct chromosome number in humans is 46, the new area of clinical cytogenetic began its rapid growth. Several major chromosomal syndromes with altered numbers of chromosomes were reported, such as Down syndrome (trisomy 21), Turner syndrome (45,X) and Klinefelter syndrome (47,XXY). Since then it has been well established that chromosome abnormalities contribute significantly to genetic disease resulting in reproductive loss, infertility, stillbirths, congenital anomalies, abnormal sexual development, mental retardation and pathogenesis of malignancy [1]. Clinical features of patients with common autosomal or sex chromosome aneuploidy is shown in Table 1. © 2015 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
    [Show full text]
  • Y Chromosome CNV Attribute to the Normal
    ical C lin as Zhang et al., J Clin Case Rep 2018, 8:6 C e f R o l e DOI: 10.4172/2165-7920.10001125 a p n o r r t u s o J Journal of Clinical Case Reports ISSN: 2165-7920 Case Report Open Access Y Chromosome CNV Attribute to the Normal Female Phenotype of a 46XX/46XY Chimerism: A Case Report Zhang H1, Gao L1, Zhao P1, Liu C1, Li W1,2, Hong M1, Zhong X1, Chen D1, Dai Y1*, Wang J1,3* and Zou C1,3* 1Department of Medicine, Clinical Medical Research Center, the Second Clinical Medical School of Jinan University, Shenzhen People’s Hospital, P.R.China 2Department of Medicine, Clinical Medical Research Center, The Second Clinical College of Jinan University, Shenzhen People’s Hospital, Shenzhen, P.R.China 3Department of Medicine, The Second Clinical College of Jinan University, Shenzhen People’s Hospital, Shenzhen, P.R.China Abstract Background: Down’s syndrome (DS) is caused by abnormal chromosome 21, which is the highest incidence of birth defect disease all the world. The phenomenon of 46XX/46XY chimeras was reported very rarely. In many cases, they were diagnosed at birth, because of the presence of ambiguous external genitalia. A case of the phenomenon of 46XX/46XY chimeras has been described in this report. Case presentation: A 23-year-old woman at 19 weeks of gestation was transferred to our hospital due to fetal chromosomal abnormalities of antenatal diagnosis. There was no abnormality of appearance through past medical history and ultrasonic examination, and hormonal levels also were normal.
    [Show full text]
  • Female Polysomy-X and Systemic Lupus Erythematosus
    Seminars in Arthritis and Rheumatism 43 (2014) 508–512 Contents lists available at ScienceDirect Seminars in Arthritis and Rheumatism journal homepage: www.elsevier.com/locate/semarthrit Female polysomy-X and systemic lupus erythematosus Mordechai Slae, MDa,n, Merav Heshin-Bekenstein, MDb, Ari Simckes, MDb, Gali Heimer, MDb, Dan Engelhard, MDb, Eli M. Eisenstein, MDc a Department of Pediatrics, University of Alberta Hospital, Edmonton, Alberta, Canada b Department of Pediatrics, Hadassah-Hebrew University Hospital at Ein Kerem, Jerusalem, Israel c Department of Pediatrics, Hadassah-Hebrew University Hospital at Mount-Scopus, Jerusalem, Israel article info abstract Objectives: Systemic lupus erythematosus (SLE) occurs more commonly in females than in males. Recent Keywords: evidence suggests that genetic factors transmitted by the X-chromosome may confer increased risk for Gene dosage autoimmune disease in general, and for SLE in particular. It is therefore possible that X-chromosome Lupus genetics polysomy might confer further increased risk for lupus. In addition to describing the clinical and Polysomy-X immunologic features of a young woman with polysomy-X and SLE, we sought to review all other Sex differences published cases associating female or male polysomy-X with SLE or other forms of autoimmunity. SLE Methods: We report a case of a prepubertal girl with polysomy-X and SLE. We performed a systemic X-chromosome literature review for cases of polysomy-X and SLE and summarize previously published cases. In addition, we reviewed reports concerning the possible association between SLE and other connective tissue diseases and male polysomy-X. Results: An 11-year-old girl with tetrasomy-X (48 XXXX karyotype) presented with prolonged fever.
    [Show full text]
  • Curriculum Vitae
    CURRICULUM VITAE David Randal Hessl, Ph.D. Department of Psychiatry and Behavioral Sciences and MIND Institute University of California Davis Medical Center 2825 50th Street Sacramento, CA 95817 (916) 703-0249 [email protected] EDUCATION Ph.D. University of Washington. Seattle, WA (1997) Major Area: Child Clinical Psychology Minor Area: Developmental Psychology Advisor: Geraldine Dawson, Ph.D. M.S. University of Washington. Seattle, WA (1995) Major Area: Child Clinical Psychology B.A. University of California, Los Angeles. Los Angeles, CA (1989) Major: Psychology ADDITIONAL TRAINING 1996 – 1997 APA Accredited Internship. Lucile Salter Packard Children’s Hospital at Stanford and The Children’s Health Council Consortium, Stanford and Palo Alto, CA. 1997 - 1998 MacArthur Foundation Post-Doctoral Fellowship. Institute of Human Development, University of California, Berkeley, CA. ACADEMIC POSITIONS 2014 – present Professor of Clinical Psychiatry. Department of Psychiatry and Behavioral Sciences and MIND Institute, University of California Davis School of Medicine, Sacramento, CA. 2008 – 2014 Associate Professor of Clinical Psychiatry. Department of Psychiatry and Behavioral Sciences and MIND Institute, University of California Davis School of Medicine, Sacramento, CA. David R. Hessl, PhD, 2 2006 – 2008 Assistant Professor of Clinical Psychiatry. Department of Psychiatry and Behavioral Sciences and MIND Institute, University of California Davis School of Medicine, Sacramento, CA. 2003 – 2006 Assistant Clinical Professor. Department of Psychiatry and Behavioral Sciences and MIND Institute, University of California Davis School of Medicine, Sacramento, CA. 2002 – 2003 Psychologist II. MIND Institute, University of California Davis School of Medicine, Sacramento, CA. 1998 - 2001 Research and Clinical Psychologist. Behavioral Neurogenetics Research Center, Division of Child Psychiatry, Stanford University School of Medicine, Stanford, CA.
    [Show full text]